cd8a pe Search Results


96
Miltenyi Biotec cd8 antibody
Cd8 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd8 antibody/product/Miltenyi Biotec
Average 96 stars, based on 1 article reviews
cd8 antibody - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
Miltenyi Biotec cd8a
Cd8a, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd8a/product/Miltenyi Biotec
Average 96 stars, based on 1 article reviews
cd8a - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

93
Proteintech pe cd8
Pe Cd8, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe cd8/product/Proteintech
Average 93 stars, based on 1 article reviews
pe cd8 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

95
Miltenyi Biotec reafinitytm miltenyi 130 119 123 cd8a antibody
Reafinitytm Miltenyi 130 119 123 Cd8a Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reafinitytm miltenyi 130 119 123 cd8a antibody/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
reafinitytm miltenyi 130 119 123 cd8a antibody - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

93
Proteintech cd8a pe
In vivo immune responses assessment. (A) Flow cytometry assay of CD80 + or CD86 + gated on CD11c + in the TDLNs of mice. (B) Flow cytometry assay illustrated the percent of <t>CD8a</t> + T cells and CD4 + T cells gated on CD3 + T cells in splenocytes of mice. (C-D) Quantitative percentages of CD80 + or CD86 + expressions gated on CD11c + according to (A). (E) Quantitative percentages of CD8a + T cells and CD4 + T cells in splenocytes according to (B). (F-H) Quantitative analysis of the immune-associated cytokines in serum, as determined by ELISA (IL-2, TNF-α and IFN-γ). ( n = 3, mean ± SD, * P < 0.05, ** P < 0.01 and ## P < 0.0001).
Cd8a Pe, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd8a pe/product/Proteintech
Average 93 stars, based on 1 article reviews
cd8a pe - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

96
Miltenyi Biotec αcd8 pe
In vivo immune responses assessment. (A) Flow cytometry assay of CD80 + or CD86 + gated on CD11c + in the TDLNs of mice. (B) Flow cytometry assay illustrated the percent of <t>CD8a</t> + T cells and CD4 + T cells gated on CD3 + T cells in splenocytes of mice. (C-D) Quantitative percentages of CD80 + or CD86 + expressions gated on CD11c + according to (A). (E) Quantitative percentages of CD8a + T cells and CD4 + T cells in splenocytes according to (B). (F-H) Quantitative analysis of the immune-associated cytokines in serum, as determined by ELISA (IL-2, TNF-α and IFN-γ). ( n = 3, mean ± SD, * P < 0.05, ** P < 0.01 and ## P < 0.0001).
αcd8 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/αcd8 pe/product/Miltenyi Biotec
Average 96 stars, based on 1 article reviews
αcd8 pe - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

94
Cytek Biosciences cd8 pe cy7
Immunophenotype Results for Male and Female Sarcospan-Deficient Mice. Flow cytometry was used to determine the % immune cell populations in splenocyte suspensions obtained from WT and SSPN -/- male and female mice. In (A) T cells, (B) plasmacytoid dendritic cells (pDCs), (C) dendritic cells (DCs), and (G) natural killer NK1.1 + cells. Representative flow spectra are shown in (D) CD4+ and <t>CD8+</t> T cells (E) pDCs, and (F) DCs. Genotype differences in the male and female mouse groups were assessed separately using the two-tailed Student’s t-test. Data shown as individual values and considered significant if p ≥ 0.05. Significant differences indicated by * for 0.05 and ** for 0.001.
Cd8 Pe Cy7, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd8 pe cy7/product/Cytek Biosciences
Average 94 stars, based on 1 article reviews
cd8 pe cy7 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
Cytek Biosciences mouse cd8a
In vivo immune responses activated by AuNP@HMV@SPs. (a) Schematic illustration of experimental design to evaluate the in vivo immune responses activated by AuNP@HMV@SPs (OMVs: 2 µg/mL, SP: 1.5 µg/mL) via subcutaneous injection. (b) Percentage of CD80 + and CD86 + cells (gated on CD11c + cells) in the lymph nodes collected on day 21 ( n = 4). (c) Percentage of GL7 + cells (gated on CD19 + IgG − cells) in the spleen collected on day 21 ( n = 5). (d) Anti‐ P. aeruginosa specific antibody IgG titers in serum collected on day 21 ( n = 5). (e) CD3 + T cells, (f) CD3 + CD4 + T cells, and (g) CD3 + <t>CD8</t> + T cells in the spleen collected on day 21 ( n = 5). Naive mice without immunization were used as control. Statistical analysis was conducted using the student's t ‐test or One‐way ANOVA with Tukey's post hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001 and ns representing non‐significance.
Mouse Cd8a, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse cd8a/product/Cytek Biosciences
Average 93 stars, based on 1 article reviews
mouse cd8a - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

95
Miltenyi Biotec anti cd8 pe
In vivo immune responses activated by AuNP@HMV@SPs. (a) Schematic illustration of experimental design to evaluate the in vivo immune responses activated by AuNP@HMV@SPs (OMVs: 2 µg/mL, SP: 1.5 µg/mL) via subcutaneous injection. (b) Percentage of CD80 + and CD86 + cells (gated on CD11c + cells) in the lymph nodes collected on day 21 ( n = 4). (c) Percentage of GL7 + cells (gated on CD19 + IgG − cells) in the spleen collected on day 21 ( n = 5). (d) Anti‐ P. aeruginosa specific antibody IgG titers in serum collected on day 21 ( n = 5). (e) CD3 + T cells, (f) CD3 + CD4 + T cells, and (g) CD3 + <t>CD8</t> + T cells in the spleen collected on day 21 ( n = 5). Naive mice without immunization were used as control. Statistical analysis was conducted using the student's t ‐test or One‐way ANOVA with Tukey's post hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001 and ns representing non‐significance.
Anti Cd8 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd8 pe/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
anti cd8 pe - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

95
Miltenyi Biotec anti cd8
In vivo immune responses activated by AuNP@HMV@SPs. (a) Schematic illustration of experimental design to evaluate the in vivo immune responses activated by AuNP@HMV@SPs (OMVs: 2 µg/mL, SP: 1.5 µg/mL) via subcutaneous injection. (b) Percentage of CD80 + and CD86 + cells (gated on CD11c + cells) in the lymph nodes collected on day 21 ( n = 4). (c) Percentage of GL7 + cells (gated on CD19 + IgG − cells) in the spleen collected on day 21 ( n = 5). (d) Anti‐ P. aeruginosa specific antibody IgG titers in serum collected on day 21 ( n = 5). (e) CD3 + T cells, (f) CD3 + CD4 + T cells, and (g) CD3 + <t>CD8</t> + T cells in the spleen collected on day 21 ( n = 5). Naive mice without immunization were used as control. Statistical analysis was conducted using the student's t ‐test or One‐way ANOVA with Tukey's post hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001 and ns representing non‐significance.
Anti Cd8, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd8/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
anti cd8 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

96
Miltenyi Biotec cd8
In vivo immune responses activated by AuNP@HMV@SPs. (a) Schematic illustration of experimental design to evaluate the in vivo immune responses activated by AuNP@HMV@SPs (OMVs: 2 µg/mL, SP: 1.5 µg/mL) via subcutaneous injection. (b) Percentage of CD80 + and CD86 + cells (gated on CD11c + cells) in the lymph nodes collected on day 21 ( n = 4). (c) Percentage of GL7 + cells (gated on CD19 + IgG − cells) in the spleen collected on day 21 ( n = 5). (d) Anti‐ P. aeruginosa specific antibody IgG titers in serum collected on day 21 ( n = 5). (e) CD3 + T cells, (f) CD3 + CD4 + T cells, and (g) CD3 + <t>CD8</t> + T cells in the spleen collected on day 21 ( n = 5). Naive mice without immunization were used as control. Statistical analysis was conducted using the student's t ‐test or One‐way ANOVA with Tukey's post hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001 and ns representing non‐significance.
Cd8, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd8/product/Miltenyi Biotec
Average 96 stars, based on 1 article reviews
cd8 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

93
Cytek Biosciences anti mouse cd8a pe
In vivo immune responses activated by AuNP@HMV@SPs. (a) Schematic illustration of experimental design to evaluate the in vivo immune responses activated by AuNP@HMV@SPs (OMVs: 2 µg/mL, SP: 1.5 µg/mL) via subcutaneous injection. (b) Percentage of CD80 + and CD86 + cells (gated on CD11c + cells) in the lymph nodes collected on day 21 ( n = 4). (c) Percentage of GL7 + cells (gated on CD19 + IgG − cells) in the spleen collected on day 21 ( n = 5). (d) Anti‐ P. aeruginosa specific antibody IgG titers in serum collected on day 21 ( n = 5). (e) CD3 + T cells, (f) CD3 + CD4 + T cells, and (g) CD3 + <t>CD8</t> + T cells in the spleen collected on day 21 ( n = 5). Naive mice without immunization were used as control. Statistical analysis was conducted using the student's t ‐test or One‐way ANOVA with Tukey's post hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001 and ns representing non‐significance.
Anti Mouse Cd8a Pe, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cd8a pe/product/Cytek Biosciences
Average 93 stars, based on 1 article reviews
anti mouse cd8a pe - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


In vivo immune responses assessment. (A) Flow cytometry assay of CD80 + or CD86 + gated on CD11c + in the TDLNs of mice. (B) Flow cytometry assay illustrated the percent of CD8a + T cells and CD4 + T cells gated on CD3 + T cells in splenocytes of mice. (C-D) Quantitative percentages of CD80 + or CD86 + expressions gated on CD11c + according to (A). (E) Quantitative percentages of CD8a + T cells and CD4 + T cells in splenocytes according to (B). (F-H) Quantitative analysis of the immune-associated cytokines in serum, as determined by ELISA (IL-2, TNF-α and IFN-γ). ( n = 3, mean ± SD, * P < 0.05, ** P < 0.01 and ## P < 0.0001).

Journal: Asian Journal of Pharmaceutical Sciences

Article Title: Lignin-assisted construction of sub-10 nm supramolecular self-assembly for photothermal immunotherapy and potentiating anti-PD-1 therapy against primary and distant breast tumors

doi: 10.1016/j.ajps.2022.07.002

Figure Lengend Snippet: In vivo immune responses assessment. (A) Flow cytometry assay of CD80 + or CD86 + gated on CD11c + in the TDLNs of mice. (B) Flow cytometry assay illustrated the percent of CD8a + T cells and CD4 + T cells gated on CD3 + T cells in splenocytes of mice. (C-D) Quantitative percentages of CD80 + or CD86 + expressions gated on CD11c + according to (A). (E) Quantitative percentages of CD8a + T cells and CD4 + T cells in splenocytes according to (B). (F-H) Quantitative analysis of the immune-associated cytokines in serum, as determined by ELISA (IL-2, TNF-α and IFN-γ). ( n = 3, mean ± SD, * P < 0.05, ** P < 0.01 and ## P < 0.0001).

Article Snippet: Fluorochrome-labeled anti-mouse monoclonal antibodies (CD11c-allophycocyanin (APC), CD80-fluorescein isothiocyanate (FITC), CD86-phycoerythrin (PE), CD3-FITC, CD8a-PE, and CD4-APC) were bought from Proteintech.

Techniques: In Vivo, Flow Cytometry, Enzyme-linked Immunosorbent Assay

Immunophenotype Results for Male and Female Sarcospan-Deficient Mice. Flow cytometry was used to determine the % immune cell populations in splenocyte suspensions obtained from WT and SSPN -/- male and female mice. In (A) T cells, (B) plasmacytoid dendritic cells (pDCs), (C) dendritic cells (DCs), and (G) natural killer NK1.1 + cells. Representative flow spectra are shown in (D) CD4+ and CD8+ T cells (E) pDCs, and (F) DCs. Genotype differences in the male and female mouse groups were assessed separately using the two-tailed Student’s t-test. Data shown as individual values and considered significant if p ≥ 0.05. Significant differences indicated by * for 0.05 and ** for 0.001.

Journal: bioRxiv

Article Title: Assessing a Role for Sarcospan in Immune Function

doi: 10.1101/2024.03.31.587501

Figure Lengend Snippet: Immunophenotype Results for Male and Female Sarcospan-Deficient Mice. Flow cytometry was used to determine the % immune cell populations in splenocyte suspensions obtained from WT and SSPN -/- male and female mice. In (A) T cells, (B) plasmacytoid dendritic cells (pDCs), (C) dendritic cells (DCs), and (G) natural killer NK1.1 + cells. Representative flow spectra are shown in (D) CD4+ and CD8+ T cells (E) pDCs, and (F) DCs. Genotype differences in the male and female mouse groups were assessed separately using the two-tailed Student’s t-test. Data shown as individual values and considered significant if p ≥ 0.05. Significant differences indicated by * for 0.05 and ** for 0.001.

Article Snippet: Cells were incubated with anti-mouse primary antibodies to assess immune populations with the following conjugated antibodies: B220-APC (Tonbo Biosciences, San Diego, CA; clone RA3-6B2), CD19-PE/Dazzle594 (BioLegend, San Diego, CA; clone 6D5), CD3-AlexaFluor488 (BioLegend, clone 17A2), CD4-violetFluor450 (Tonbo Biosciences, clone GK1.5), CD8-PE/Cy7 (Tonbo Biosciences, clone 53-6.7), NK1.1-PE (Tonbo Biosciences, clone PK136), CD335/NKp46-APC (BioLegend, clone 29A1.4), CD11b-APC/Cy7 (Tonbo Biosciences, clone M1/70), CD11c-PerCp/Cy5.5 (Tonbo Biosciences, clone N418), Ly6G-PE (Tonbo Biosciences, clone RB6-8C5), and F4/80-FITC (Tonbo Biosciences, clone BM8.1,).

Techniques: Flow Cytometry, Two Tailed Test, IF-P

In vivo immune responses activated by AuNP@HMV@SPs. (a) Schematic illustration of experimental design to evaluate the in vivo immune responses activated by AuNP@HMV@SPs (OMVs: 2 µg/mL, SP: 1.5 µg/mL) via subcutaneous injection. (b) Percentage of CD80 + and CD86 + cells (gated on CD11c + cells) in the lymph nodes collected on day 21 ( n = 4). (c) Percentage of GL7 + cells (gated on CD19 + IgG − cells) in the spleen collected on day 21 ( n = 5). (d) Anti‐ P. aeruginosa specific antibody IgG titers in serum collected on day 21 ( n = 5). (e) CD3 + T cells, (f) CD3 + CD4 + T cells, and (g) CD3 + CD8 + T cells in the spleen collected on day 21 ( n = 5). Naive mice without immunization were used as control. Statistical analysis was conducted using the student's t ‐test or One‐way ANOVA with Tukey's post hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001 and ns representing non‐significance.

Journal: Journal of Extracellular Vesicles

Article Title: A multiantigenic antibacterial nanovaccine utilizing hybrid membrane vesicles for combating Pseudomonas aeruginosa infections

doi: 10.1002/jev2.12524

Figure Lengend Snippet: In vivo immune responses activated by AuNP@HMV@SPs. (a) Schematic illustration of experimental design to evaluate the in vivo immune responses activated by AuNP@HMV@SPs (OMVs: 2 µg/mL, SP: 1.5 µg/mL) via subcutaneous injection. (b) Percentage of CD80 + and CD86 + cells (gated on CD11c + cells) in the lymph nodes collected on day 21 ( n = 4). (c) Percentage of GL7 + cells (gated on CD19 + IgG − cells) in the spleen collected on day 21 ( n = 5). (d) Anti‐ P. aeruginosa specific antibody IgG titers in serum collected on day 21 ( n = 5). (e) CD3 + T cells, (f) CD3 + CD4 + T cells, and (g) CD3 + CD8 + T cells in the spleen collected on day 21 ( n = 5). Naive mice without immunization were used as control. Statistical analysis was conducted using the student's t ‐test or One‐way ANOVA with Tukey's post hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001 and ns representing non‐significance.

Article Snippet: FITC‐conjugated anti‐mouse CD11c, PE‐conjugated anti‐mouse CD80, APC‐conjugated anti‐mouse CD86, APC‐conjugated anti‐mouse CD3, PE‐conjugated anti‐mouse CD8a, FITC‐conjugated anti‐mouse CD4, and PE‐conjugated anti‐mouse CD19 were purchased from Tonbo Biosciences, U.S.A.. APC‐conjugated anti‐mouse GL‐7 was obtained from Laizee Biotech, Shanghai, China.

Techniques: In Vivo, Injection, Control